Literature DB >> 23037965

The treatment of alcohol and opioid dependence in pregnant women.

Annemarie Heberlein1, Lorenzo Leggio, Dirk Stichtenoth, Thomas Hillemacher.   

Abstract

PURPOSE OF REVIEW: This article addresses the question of 'best treatment options', which clinicians face when treating pregnant women with alcohol and opioid dependence. RECENT
FINDINGS: Studies show that alcohol consumption is associated with fetal abnormalities and long-term cognitive problems depending on the amount consumed, drinking pattern, and time of gestation. Screening and evaluation of specific interventions are important to reduce alcohol consumption during pregnancy and associated problems in infants. Opioid detoxification is only recommended beyond the first trimester and only in those pregnant women who refuse opioid maintenance therapy. Methadone is the most established treatment of pregnant opioid-dependent women, though recent results indicate some advantages of buprenorphine, slow-release oral methadone and diamorphine compared with methadone.
SUMMARY: Benzodiazepines seem to be the most recommendable option for managing alcohol withdrawal, and psychosocial interventions succeed in reducing alcohol consumption or in maintaining abstinence in alcohol-dependent pregnant women. Regarding opioid dependence, current results suggest that factors like the health status of the mother, the need for additional medications (e.g. treatment for HIV), comorbid drug dependence, and concurrent drug use need to be considered in order to find the 'best opioid substitute'.

Entities:  

Mesh:

Year:  2012        PMID: 23037965      PMCID: PMC4976292          DOI: 10.1097/YCO.0b013e328358ad36

Source DB:  PubMed          Journal:  Curr Opin Psychiatry        ISSN: 0951-7367            Impact factor:   4.741


  81 in total

Review 1.  Intrauterine abstinence syndrome (IAS) during buprenorphine inductions and methadone tapers: can we assure the safety of the fetus?

Authors:  John J McCarthy
Journal:  J Matern Fetal Neonatal Med       Date:  2011-08-25

2.  Brief intervention for prenatal alcohol use: a randomized trial.

Authors:  Grace Chang; Tay K McNamara; E John Orav; Danielle Koby; Alyson Lavigne; Barbara Ludman; Nori Ann Vincitorio; Louise Wilkins-Haug
Journal:  Obstet Gynecol       Date:  2005-05       Impact factor: 7.661

3.  Brief intervention for alcohol use in pregnancy: a randomized trial.

Authors:  G Chang; L Wilkins-Haug; S Berman; M A Goetz
Journal:  Addiction       Date:  1999-10       Impact factor: 6.526

Review 4.  Valproic acid monotherapy in pregnancy and major congenital malformations.

Authors:  Janneke Jentink; Maria A Loane; Helen Dolk; Ingeborg Barisic; Ester Garne; Joan K Morris; Lolkje T W de Jong-van den Berg
Journal:  N Engl J Med       Date:  2010-06-10       Impact factor: 91.245

Review 5.  Systematic review of effects of low-moderate prenatal alcohol exposure on pregnancy outcome.

Authors:  J Henderson; R Gray; P Brocklehurst
Journal:  BJOG       Date:  2007-01-12       Impact factor: 6.531

Review 6.  Opioid dependence and pregnancy.

Authors:  Bernadette Winklbaur; Erika Jung; Gabriele Fischer
Journal:  Curr Opin Psychiatry       Date:  2008-05       Impact factor: 4.741

7.  Lack of relation of oral clefts to diazepam use during pregnancy.

Authors:  L Rosenberg; A A Mitchell; J L Parsells; H Pashayan; C Louik; S Shapiro
Journal:  N Engl J Med       Date:  1983-11-24       Impact factor: 91.245

8.  Using naltrexone implants in the management of the pregnant heroin user.

Authors:  G Hulse; G O'Neil
Journal:  Aust N Z J Obstet Gynaecol       Date:  2002-11       Impact factor: 2.100

9.  Benzodiazepine use in pregnancy and major malformations or oral cleft: meta-analysis of cohort and case-control studies.

Authors:  L R Dolovich; A Addis; J M Vaillancourt; J D Power; G Koren; T R Einarson
Journal:  BMJ       Date:  1998-09-26

Review 10.  Treatment of opioid-dependent pregnant women: clinical and research issues.

Authors:  Hendree E Jones; Peter R Martin; Sarah H Heil; Karol Kaltenbach; Peter Selby; Mara G Coyle; Susan M Stine; Kevin E O'Grady; Amelia M Arria; Gabriele Fischer
Journal:  J Subst Abuse Treat       Date:  2008-01-14
View more
  7 in total

1.  Sexual Risk among Pregnant Women at Risk of HIV Infection in Cape Town, South Africa: What Does Alcohol Have to Do with It?

Authors:  Amanda P Miller; Steven Shoptaw; Rufaro Mvududu; Nyiko Mashele; Thomas J Coates; Linda-Gail Bekker; Zaynab Essack; Candice Groenewald; Zaino Petersen; Pamina M Gorbach; Landon Myer; Dvora L Joseph Davey
Journal:  AIDS Behav       Date:  2022-06-23

2.  Evidence for the Normalization Effects of Medication for Opioid Use Disorder on Functional Connectivity in Neonates with Prenatal Opioid Exposure.

Authors:  Janelle Liu; Karen Grewen; Wei Gao
Journal:  J Neurosci       Date:  2022-05-12       Impact factor: 6.709

3.  Maternal opioid drug use during pregnancy and its impact on perinatal morbidity, mortality, and the costs of medical care in the United States.

Authors:  Valerie E Whiteman; Jason L Salemi; Mulubrhan F Mogos; Mary Ashley Cain; Muktar H Aliyu; Hamisu M Salihu
Journal:  J Pregnancy       Date:  2014-08-28

Review 4.  Early life stress and environmental influences on the neurodevelopment of children with prenatal opioid exposure.

Authors:  Elisabeth Conradt; Sheila E Crowell; Barry M Lester
Journal:  Neurobiol Stress       Date:  2018-08-15

5.  Concurrent Opioid and Alcohol Use Among Women Who Become Pregnant: Historical, Current, and Future Perspectives.

Authors:  Stacey L Klaman; Kim Andringa; Evette Horton; Hendrée E Jones
Journal:  Subst Abuse       Date:  2019-05-30

6.  The Negative Impact of Maternal Perinatal Opioid Use on Neonatal Outcomes.

Authors:  Kriti D Gandhi; Kathryn M Schak; Jennifer L Vande; Julia Shekunov; Brian A Lynch; Teresa A Rummans; Jennifer R Geske; Eric R Pease; Mara G Limbeck; Jinal Desai; Paul E Croarkin; Magdalena Romanowicz
Journal:  Prim Care Companion CNS Disord       Date:  2021-06-10

7.  Alcohol Use Disorders and Increased Risk of Adverse Birth Complications and Outcomes: An 11-Year Nationwide Cohort Study.

Authors:  Sarah Soyeon Oh; Yongho Jee; Eun-Cheol Park; Young Ju Kim
Journal:  Int J Environ Res Public Health       Date:  2020-11-17       Impact factor: 3.390

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.